Concepedia

Mauro Romanenghi

MR

9

Publications

558

Citations

9

H-Index

2009

Active since

Affiliations

European Institute of Oncology(Current)

University of Milan

University of Naples Federico II

IFOM

Istituti di Ricovero e Cura a Carattere Scientifico

Mauro Romanenghi is an author at European Institute of Oncology specializing in medicine, pharmacology, and drug discovery.

Top concepts

Publications per year

2009–2023

9

Publications

9

Biochemical, Structural, and Biological Evaluation of Tranylcypromine Derivatives as Inhibitors of Histone Demethylases LSD1 and LSD2

Claudia Binda, Sérgio Valente, Mauro Romanenghi et al. · Journal of the American Chemical Society · 2010 · 283 citations

, , +16

Chromatin accessibility, p300, and histone acetylation define PML-RARα and AML1-ETO binding sites in acute myeloid leukemia

Sadia Saeed, Colin Logie, Kees-Jan Francoijs et al. · Blood · 2012 · 65 citations · Full text

NA-Seq: A Discovery Tool for the Analysis of Chromatin Structure and Dynamics during Differentiation

Gaetano Gargiulo, Samuel Lévy, Gabriele Bucci et al. · Developmental Cell · 2009 · 54 citations · Full text

, , +11

CDK12 promotes tumorigenesis but induces vulnerability to therapies inhibiting folate one-carbon metabolism in breast cancer

Maria Grazia Filippone, Daniela Gaglio, R. Bonfanti et al. · Nature Communications · 2022 · 43 citations · Full text

The DNA demethylating agent decitabine activates the TRAIL pathway and induces apoptosis in acute myeloid leukemia

Matías Soncini, Fabio Santoro, Arantxa Gutiérrez et al. · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · 2012 · 31 citations

, , +10

Rows per page

1–5 of 9